pegylated interferon alfaPEG-IFNHBsAg-lowering agentshepatocellular carcinomachronic hepatitis Bcirrhosisantiviral therapy
…NA therapy.1 The 2025 EASL guidelines accordingly still include pegylated interferon alfa (PEG-IFN) as an option for therapy in selected patients, given …